Danish Medicines Agency seeks EU review of Ozempic over risk of rare vision loss

The Danish Medicines Agency will ask the European Pharmacovigilance Risk Assessment Committee to assess two pivotal studies from the University of Southern Denmark that point to a possible risk of...